Asuragen Incorporated

Austin, TX Part of Bio-Techne Corporation

UEI
E8M9NXN4X4Y7
CAGE
4GGP6
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
2150 Woodward St #100, Austin, TX 78744, USA
Website
asuragen.com
Founded
2006
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Asuragen Incorporated's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Armored RNA Contract · 75D30123P15844 CDC Pittsburgh $75,075
Quantidex qpcr BCR ABL is kit reagents and quantidex qpcr BCR-ABL minor kit reagents. Contract · W81K0022P0237 Medical Command $552,493
Armored RNA Contract · 75D30121P12399 CDC Pittsburgh $15,075
Asuragen quantidex qpcr BCR-ABL is kit Contract · 36C25620P0029 Veterans Integrated Service Network 16 $0
Novel strategies for development of a multiplexed test with expanded content for spinal muscular atrophy Grant · R43NS115425 National Institute of Neurological Disorders and Stroke $182,393

About Asuragen Incorporated

Asuragen, Inc. is a molecular diagnostics company that provides genetics and oncology testing kits to streamline workflows for clinical research and laboratories. Through prime federal contract awards, Asuragen has provided reagents, kits, and testing materials compatible with specialized medical equipment used for cancer and leukemia testing at Army medical facilities and VA health networks. These awards have been primarily purchase orders and definitive contracts with no set-aside designations, stemming from the Department of Defense, Veterans Affairs, and Health and Human Services.

Asuragen's federal contract awards have delivered Quantidex PCR reagents, Armored RNA, and BCR ABL reagents used specifically with Applied Biosystems instrumentation and compatible with unique testing procedures at government medical centers. Performance periods for these awards range between 2019-2027, with obligations between $15,000 to over $800,000 to supply quantities of Asuragen's proprietary reagents and kits meeting specialized compatibility and FDA approval requirements. No subcontractors are noted on the available prime contract award details.

Through NIH and NICHD grants, Asuragen has also conducted research to develop multiplexed tests for spinal muscular atrophy, carrier screening for hemoglobinopathies, and prenatal testing methods using microfluidic technology. Additional grants have funded projects applying deep learning and AI tools for enhancing molecular diagnostics, as well as developing unified workflows to screen for inherited ataxias. These grants provided between $180,000 to $220,000 in assistance, with performance periods ranging from 2019-2021. No subrecipients are noted on the available prime grant award details.

Quick answers

What is Asuragen Incorporated's UEI?

Asuragen Incorporated's Unique Entity ID (UEI) in SAM.gov is E8M9NXN4X4Y7.

What is Asuragen Incorporated's CAGE code?

Asuragen Incorporated's CAGE code is 4GGP6.

What is Asuragen Incorporated's primary NAICS code?

Asuragen Incorporated's primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Asuragen Incorporated located?

Asuragen Incorporated's physical address in SAM.gov is 2150 Woodward St #100, Austin, TX 78744, USA.

Is Asuragen Incorporated registered in SAM.gov?

Yes. Asuragen Incorporated's SAM.gov registration is active through January 7, 2027.

Who is Asuragen Incorporated's parent company?

Asuragen Incorporated is part of Bio-Techne Corporation.

What is Asuragen Incorporated's most recent federal award?

Asuragen Incorporated's most recent federal contract award is Armored RNA (75D30123P15844), from CDC Pittsburgh, on December 5, 2022.

On GovTribe

See Asuragen Incorporated's full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors